Dr. Kenneth H Yu, M.D.
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Pancreatic Cancer
Studies Breast Cancer
8 reported clinical trials
21 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
BRCA1 positive
2Breast Cancer
Stage IV
BRCA1 positive
BRCA2 positive
Affiliated Hospitals
Clinical Trials Kenneth H Yu, M.D. is currently running
Chemotherapy + Stem Cell Transplant
for Pancreatic Cancer
The clinical trial is a phase 1, single-arm trial that will evaluate the safety of the investigational treatment on metastatic cancer in patients who have a deleterious or suspected deleterious BRCA1, BRCA2, or PALB2 genetic alteration. The investigational treatment will involve 2 cycles of a combination of intravenous melphalan, BCNU, low-dose I.V. ethanol, vitamin B12b, and vitamin C in association with autologous hematopoietic stem cell infusion. A dose-escalation schedule will be employed for vitamin C.
Recruiting1 award Phase 115 criteria
CX-5461
for Solid Cancers
This is an open-label, multi-center, phase 1b study designed to determine a tolerable dose of CX-5461 administered by IV infusion on Day 1 and Day 8 of a 28-day cycle in patients with selected solid tumours and associated mutations for future Phase II trials. The safety and tolerability of CX-5461, preliminary evidence of antitumor effect and the effect of CX-5461 on the Health-Related Quality of Life (HRQoL) will also be evaluated. The study will also evaluate the predictive value of mutational signatures and explore the significance of dynamic changes in ctDNA levels and plasma DNA methylome profiling in this study's exploratory cohort.
Recruiting1 award Phase 110 criteria
More about Kenneth H Yu, M.D.
Clinical Trial Related8 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Kenneth H Yu, M.D. has experience with
- Anti-EGFR-bispecific Antibody Armed Activated T-cells
- Gemcitabine
- Nab-paclitaxel
- PEGPH20
- Autologous Hematopoietic Stem Cells
- BCNU
Breakdown of trials Kenneth H Yu, M.D. has run
Pancreatic Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kenneth H Yu, M.D. specialize in?
Kenneth H Yu, M.D. focuses on Pancreatic Cancer and Breast Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Kenneth H Yu, M.D. currently recruiting for clinical trials?
Yes, Kenneth H Yu, M.D. is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Kenneth H Yu, M.D. has studied deeply?
Yes, Kenneth H Yu, M.D. has studied treatments such as anti-EGFR-bispecific antibody armed activated T-cells, Gemcitabine, Nab-paclitaxel.
What is the best way to schedule an appointment with Kenneth H Yu, M.D.?
Apply for one of the trials that Kenneth H Yu, M.D. is conducting.
What is the office address of Kenneth H Yu, M.D.?
The office of Kenneth H Yu, M.D. is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.